Page last updated: 2024-08-18

cyclohexanol and Nausea

cyclohexanol has been researched along with Nausea in 38 studies

Research

Studies (38)

TimeframeStudies, this research(%)All Research%
pre-19901 (2.63)18.7374
1990's17 (44.74)18.2507
2000's15 (39.47)29.6817
2010's5 (13.16)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ii, Y; Tourian, K; Wang, Y1
Feiger, AD; Padmanabhan, SK; Rosas, GR; Tourian, KA1
Pae, CU1
Bonelli, RM; Holl, AK; Holl, EM; Painold, A; Wilkinson, L1
Filatova, EG; Latysheva, NV; Naprienko, MV1
Astl, D; Ausmanas, MK; Cheng, RF; Gallagher, JC; Seljan, P; Strzinek, RA1
Canny, LM; Coleman, KA; Meaney, JV; Palmer, TL; Radalj, LM; Xavier, VY1
DeVane, CL1
Bothmer, J; Huusom, AK; Montgomery, SA1
Hindmarch, I; Rigney, U; Stanley, N; Trick, L1
Gelenberg, AJ; Liebowitz, MR; Munjack, D1
Anderson, C; Baile, W; Cinciripini, L; Cinciripini, PM; de Moor, C; Lam, C; Minna, JD; Tsoh, JY; Wetter, DW1
Bahk, WM; Chae, JH; Jun, TY; Kim, TS; Pae, CU; Rhee, WI; Yoon, SJ1
Ahmed, S; Baldwin, D; Benattia, I; Davidson, J; Kuper, E; Musgnung, J; Pedersen, R; Stein, DJ1
Germain, JM; Padmanabhan, SK; Pitrosky, B; Septien-Velez, L; Tourian, KA1
Aviv, A; Barak, Y; Mazeh, D; Shahal, B; Zemishlani, H1
Han, C; Joe, SH; Jung, IK; Ko, YH; Lee, BH; Masand, PS; Pae, CU; Patkar, AA1
Farah, A; Lauer, TE1
Russell, JL1
Kirsch, MA; Lannon, RA; Lewis, TB; Louie, AK1
Haddad, P1
Nelson, JC1
Mitchell, S; Tracy, KA; Zajecka, J1
Thase, ME1
Albano, D; Amchin, J1
Entsuah, R; Khan, A; Leventer, SM; Rudolph, RL; Upton, GV1
Chitra, R; Entsuah, R1
Derivan, AT; Entsuah, R; Fabre, LF; Feighner, JP; Rickels, K; Rudolph, RL1
Ansseau, M1
Macbeth, R; Rajagopalan, M1
Boyd, IW1
Joffe, RT; Lee, DK; Marshall, AM1
McAllister-Williams, RH; Porter, RJ; Young, AH1
Batchelder, ST; Fedak, MJ; Hellerstein, DJ; Kreditor, D; Little, SA; Rosenthal, J1
Behnke, K; Mehtonen, OP; Roponen, P; Søgaard, J1
Jacob, C; Luckhaus, C1
Chaturachinda, K; O-Prasertsawat, P; Padmasuta, K; Pausawasdi, S; Tangtrakul, S1

Reviews

5 review(s) available for cyclohexanol and Nausea

ArticleYear
Desvenlafaxine: a new antidepressant or just another one?
    Expert opinion on pharmacotherapy, 2009, Volume: 10, Issue:5

    Topics: Animals; Antidepressive Agents; Cyclohexanols; Depressive Disorder, Major; Desvenlafaxine Succinate; Humans; Nausea; Randomized Controlled Trials as Topic

2009
Immediate-release versus controlled-release formulations: pharmacokinetics of newer antidepressants in relation to nausea.
    The Journal of clinical psychiatry, 2003, Volume: 64 Suppl 18

    Topics: Antidepressive Agents; Bupropion; Cyclohexanols; Delayed-Action Preparations; Drug Tolerance; Half-Life; Humans; Nausea; Paroxetine; Randomized Controlled Trials as Topic; Venlafaxine Hydrochloride

2003
Newer antidepressants and the discontinuation syndrome.
    The Journal of clinical psychiatry, 1997, Volume: 58 Suppl 7

    Topics: Adverse Drug Reaction Reporting Systems; Cyclohexanols; Dizziness; Fluoxetine; Headache; Humans; Incidence; Nausea; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sleep Stages; Substance Withdrawal Syndrome; Syndrome; Venlafaxine Hydrochloride

1997
Safety and tolerability of the new antidepressants.
    The Journal of clinical psychiatry, 1997, Volume: 58 Suppl 6

    Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Depressive Disorder; Headache; Humans; Mianserin; Mirtazapine; Nausea; Piperazines; Selective Serotonin Reuptake Inhibitors; Sleep Initiation and Maintenance Disorders; Triazoles; Venlafaxine Hydrochloride

1997
Discontinuation symptoms after treatment with serotonin reuptake inhibitors: a literature review.
    The Journal of clinical psychiatry, 1997, Volume: 58, Issue:7

    Topics: 1-Naphthylamine; Adolescent; Adult; Child; Clinical Trials as Topic; Cyclohexanols; Dizziness; Female; Fluoxetine; Fluvoxamine; Headache; Humans; Infant; Infant, Newborn; Male; MEDLINE; Mental Disorders; Middle Aged; Nausea; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sensation Disorders; Sertraline; Sleep Initiation and Maintenance Disorders; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride

1997

Trials

23 trial(s) available for cyclohexanol and Nausea

ArticleYear
A 10-month, open-label evaluation of desvenlafaxine in Japanese outpatients with major depressive disorder.
    International clinical psychopharmacology, 2013, Volume: 28, Issue:4

    Topics: Adult; Antidepressive Agents; Cyclohexanols; Depressive Disorder, Major; Desvenlafaxine Succinate; Diagnostic and Statistical Manual of Mental Disorders; Disorders of Excessive Somnolence; Drug Monitoring; Female; Headache; Humans; Incidence; Intention to Treat Analysis; Japan; Male; Middle Aged; Nasopharyngitis; Nausea; Neurotransmitter Uptake Inhibitors; Psychiatric Status Rating Scales

2013
A placebo-controlled study evaluating the efficacy and safety of flexible-dose desvenlafaxine treatment in outpatients with major depressive disorder.
    CNS spectrums, 2009, Volume: 14, Issue:1

    Topics: Adolescent; Adult; Aged; Antidepressive Agents; Cyclohexanols; Depressive Disorder, Major; Desvenlafaxine Succinate; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Nausea; Outpatients; Placebos; Treatment Outcome; Young Adult

2009
Combating depression in Huntington's disease: effective antidepressive treatment with venlafaxine XR.
    International clinical psychopharmacology, 2010, Volume: 25, Issue:1

    Topics: Antidepressive Agents, Second-Generation; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder, Major; Female; Humans; Huntington Disease; Irritable Mood; Male; Middle Aged; Nausea; Treatment Outcome; Venlafaxine Hydrochloride

2010
The effect of dose titration and dose tapering on the tolerability of desvenlafaxine in women with vasomotor symptoms associated with menopause.
    Journal of women's health (2002), 2012, Volume: 21, Issue:2

    Topics: Aged; Cyclohexanols; Desvenlafaxine Succinate; Dose-Response Relationship, Drug; Double-Blind Method; Female; Hot Flashes; Humans; Middle Aged; Nausea; Neurotransmitter Uptake Inhibitors; Patient Satisfaction; Postmenopause; Vasomotor System

2012
A randomised study comparing escitalopram with venlafaxine XR in primary care patients with major depressive disorder.
    Neuropsychobiology, 2004, Volume: 50, Issue:1

    Topics: Adult; Antidepressive Agents, Second-Generation; Citalopram; Constipation; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Double-Blind Method; Female; Humans; Male; Middle Aged; Nausea; Primary Health Care; Psychiatric Status Rating Scales; Sweating; Treatment Outcome; Venlafaxine Hydrochloride

2004
A double-blind, randomized, 26-week study comparing the cognitive and psychomotor effects and efficacy of 75 mg (37.5 mg b.i.d.) venlafaxine and 75 mg (25 mg mane, 50 mg nocte) dothiepin in elderly patients with moderate major depression being treated in
    Journal of psychopharmacology (Oxford, England), 2004, Volume: 18, Issue:2

    Topics: Aged; Cognition; Cyclohexanols; Depressive Disorder; Disorders of Excessive Somnolence; Dizziness; Dothiepin; Double-Blind Method; Drug Administration Schedule; Female; Flicker Fusion; Humans; Male; Narcolepsy; Nausea; Psychometrics; Psychomotor Performance; Time Factors; Venlafaxine Hydrochloride

2004
Venlafaxine extended release vs placebo and paroxetine in social anxiety disorder.
    Archives of general psychiatry, 2005, Volume: 62, Issue:2

    Topics: Adult; Cyclohexanols; Delayed-Action Preparations; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Nausea; Paroxetine; Phobic Disorders; Placebos; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sleep Initiation and Maintenance Disorders; Treatment Outcome; Venlafaxine Hydrochloride

2005
Combined effects of venlafaxine, nicotine replacement, and brief counseling on smoking cessation.
    Experimental and clinical psychopharmacology, 2005, Volume: 13, Issue:4

    Topics: Administration, Cutaneous; Antidepressive Agents, Second-Generation; Counseling; Cyclohexanols; Diarrhea; Dizziness; Dose-Response Relationship, Drug; Double-Blind Method; Female; Headache; Humans; Male; Middle Aged; Nausea; Nicotine; Nicotinic Agonists; Patient Selection; Smoking; Smoking Cessation; Substance Withdrawal Syndrome; Time Factors; Tobacco Use Disorder; Treatment Outcome; Venlafaxine Hydrochloride

2005
Comparison of venlafaxine extended release versus paroxetine for treatment of patients with generalized anxiety disorder.
    Psychiatry and clinical neurosciences, 2006, Volume: 60, Issue:3

    Topics: Adult; Analysis of Variance; Antidepressive Agents, Second-Generation; Anxiety Disorders; Cyclohexanols; Delayed-Action Preparations; Drug Administration Schedule; Female; Headache; Humans; Male; Middle Aged; Nausea; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sweating; Venlafaxine Hydrochloride; Weight Gain

2006
Treatment of posttraumatic stress disorder with venlafaxine extended release: a 6-month randomized controlled trial.
    Archives of general psychiatry, 2006, Volume: 63, Issue:10

    Topics: Adult; Ambulatory Care; Cyclohexanols; Delayed-Action Preparations; Dizziness; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Headache; Humans; Longitudinal Studies; Male; Nausea; Placebos; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Stress Disorders, Post-Traumatic; Treatment Outcome; Venlafaxine Hydrochloride

2006
A randomized, double-blind, placebo-controlled trial of desvenlafaxine succinate in the treatment of major depressive disorder.
    International clinical psychopharmacology, 2007, Volume: 22, Issue:6

    Topics: Adolescent; Adult; Aged; Antidepressive Agents; Cyclohexanols; Depressive Disorder, Major; Desvenlafaxine Succinate; Dizziness; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Male; Middle Aged; Nausea; Patient Dropouts; Psychiatric Status Rating Scales; Sex Factors; Sweating; Treatment Outcome

2007
A randomized, single-blind, comparison of venlafaxine with paroxetine in elderly patients suffering from resistant depression.
    International clinical psychopharmacology, 2007, Volume: 22, Issue:6

    Topics: Aged; Aged, 80 and over; Antidepressive Agents, Second-Generation; Cyclohexanols; Depression; Diagnostic and Statistical Manual of Mental Disorders; Dizziness; Dose-Response Relationship, Drug; Drug Resistance; Female; Humans; Male; Nausea; Paroxetine; Psychiatric Status Rating Scales; Remission Induction; Selective Serotonin Reuptake Inhibitors; Single-Blind Method; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride; Xerostomia

2007
Venlafaxine versus mirtazapine in the treatment of undifferentiated somatoform disorder: a 12-week prospective, open-label, randomized, parallel-group trial.
    Clinical drug investigation, 2008, Volume: 28, Issue:4

    Topics: Adult; Antidepressive Agents; Cyclohexanols; Diagnostic and Statistical Manual of Mental Disorders; Disorders of Excessive Somnolence; Dizziness; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Mianserin; Middle Aged; Mirtazapine; Nausea; Patient Dropouts; Prospective Studies; Somatoform Disorders; Surveys and Questionnaires; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride; Xerostomia; Yawning

2008
Relatively low doses of cisapride in the treatment of nausea in patients treated with venlafaxine for treatment-refractory depression.
    Journal of clinical psychopharmacology, 1996, Volume: 16, Issue:1

    Topics: Adult; Antidepressive Agents, Second-Generation; Cisapride; Cyclohexanols; Depressive Disorder; Drug Resistance; Female; Humans; Male; Middle Aged; Nausea; Piperidines; Psychiatric Status Rating Scales; Serotonin Antagonists; Venlafaxine Hydrochloride

1996
Efficacy and tolerability of once-daily venlafaxine extended release (XR) in outpatients with major depression. The Venlafaxine XR 209 Study Group.
    The Journal of clinical psychiatry, 1997, Volume: 58, Issue:9

    Topics: Adult; Ambulatory Care; Antidepressive Agents, Second-Generation; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Nausea; Placebos; Psychiatric Status Rating Scales; Severity of Illness Index; Sleep Initiation and Maintenance Disorders; Treatment Outcome; Venlafaxine Hydrochloride

1997
The use of venlafaxine in the treatment of major depression and major depression associated with anxiety: a dose-response study. Venlafaxine Investigator Study Group.
    Journal of clinical psychopharmacology, 1998, Volume: 18, Issue:1

    Topics: Adult; Antidepressive Agents, Second-Generation; Anxiety Disorders; Cyclohexanols; Depressive Disorder; Dizziness; Double-Blind Method; Female; Humans; Male; Nausea; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride

1998
A benefit-risk analysis of once-daily venlafaxine extended release (XR) and venlafaxine immediate release (IR) in outpatients with major depression.
    Psychopharmacology bulletin, 1997, Volume: 33, Issue:4

    Topics: Antidepressive Agents, Second-Generation; Cost-Benefit Analysis; Cyclohexanols; Delayed-Action Preparations; Depressive Disorder; Dizziness; Humans; Nausea; Selective Serotonin Reuptake Inhibitors; Statistics as Topic; Venlafaxine Hydrochloride

1997
A randomized, placebo-controlled, dose-response trial of venlafaxine hydrochloride in the treatment of major depression.
    The Journal of clinical psychiatry, 1998, Volume: 59, Issue:3

    Topics: Adult; Aged; Ambulatory Care; Anorexia; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Dizziness; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Nausea; Placebos; Psychiatric Status Rating Scales; Sleep Wake Disorders; Treatment Outcome; Venlafaxine Hydrochloride

1998
A large open-label study of venlafaxine in depressed outpatients by community-based physicians.
    The Journal of clinical psychiatry, 1998, Volume: 59, Issue:10

    Topics: Adolescent; Adult; Aged; Ambulatory Care; Antidepressive Agents, Second-Generation; Community Medicine; Cyclohexanols; Depressive Disorder; Drug Administration Schedule; Dysthymic Disorder; Family Practice; Female; Humans; Male; Middle Aged; Nausea; Psychiatric Status Rating Scales; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride; Xerostomia

1998
Acute effects of venlafaxine and paroxetine on serotonergic transmission in human volunteers.
    Psychopharmacology, 1999, Volume: 146, Issue:2

    Topics: Adolescent; Adult; Area Under Curve; Clomipramine; Cyclohexanols; Human Growth Hormone; Humans; Male; Nausea; Paroxetine; Prolactin; Selective Serotonin Reuptake Inhibitors; Serotonin; Synaptic Transmission; Tryptophan; Venlafaxine Hydrochloride; Vomiting

1999
Venlafaxine in the treatment of dysthymia: an open-label study.
    The Journal of clinical psychiatry, 1999, Volume: 60, Issue:12

    Topics: Antidepressive Agents, Second-Generation; Cyclohexanols; Drug Administration Schedule; Dysthymic Disorder; Fatigue; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nausea; Patient Dropouts; Psychiatric Status Rating Scales; Treatment Outcome; Venlafaxine Hydrochloride; Xerostomia

1999
Randomized, double-blind comparison of venlafaxine and sertraline in outpatients with major depressive disorder. Venlafaxine 631 Study Group.
    The Journal of clinical psychiatry, 2000, Volume: 61, Issue:2

    Topics: Adult; Aged; Ambulatory Care; Cyclohexanols; Depressive Disorder; Diarrhea; Dizziness; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Headache; Humans; Male; Middle Aged; Nausea; Psychiatric Status Rating Scales; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome; Venlafaxine Hydrochloride

2000
A comparative study of tramadol and pethidine in laparoscopic interval sterilization.
    Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 1988, Volume: 71 Suppl 1

    Topics: Adult; Analgesia; Clinical Trials as Topic; Cyclohexanols; Female; Humans; Meperidine; Nausea; Sterilization, Tubal; Tramadol; Vomiting

1988

Other Studies

10 other study(ies) available for cyclohexanol and Nausea

ArticleYear
[New approaches to the treatment of chronic daily headache].
    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2010, Volume: 110, Issue:9

    Topics: Adult; Aminopyridines; Analgesics; Attention Deficit Disorder with Hyperactivity; Constipation; Cyclohexanols; Diarrhea; Female; Headache Disorders; Humans; Male; Nausea; Pain Threshold; Treatment Outcome; Venlafaxine Hydrochloride

2010
An indirect comparison of the efficacy and safety of desvenlafaxine and venlafaxine using placebo as the common comparator.
    CNS spectrums, 2012, Volume: 17, Issue:3

    Topics: Adult; Aged; Antidepressive Agents; Australia; Bayes Theorem; Cyclohexanols; Databases, Factual; Depressive Disorder, Major; Desvenlafaxine Succinate; Double-Blind Method; Female; Humans; Male; Meta-Analysis as Topic; Middle Aged; Nausea; Psychiatric Status Rating Scales; Randomized Controlled Trials as Topic; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult

2012
Possible venlafaxine withdrawal syndrome.
    The American journal of psychiatry, 1996, Volume: 153, Issue:4

    Topics: Adult; Cyclohexanols; Depressive Disorder; Fatigue; Female; Gastrointestinal Diseases; Headache; Humans; Nausea; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Tinnitus; Venlafaxine Hydrochloride

1996
Venlafaxine withdrawal reactions.
    The American journal of psychiatry, 1996, Volume: 153, Issue:12

    Topics: Cyclohexanols; Depressive Disorder; Dizziness; Female; Humans; Male; Middle Aged; Nausea; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride

1996
Clinical considerations in managing nausea associated with venlafaxine.
    Journal of clinical psychopharmacology, 1997, Volume: 17, Issue:6

    Topics: Antidepressive Agents, Second-Generation; Cisapride; Cyclohexanols; Depressive Disorder; Gastrointestinal Agents; Humans; Nausea; Piperidines; Venlafaxine Hydrochloride

1997
[Pharma-Clinics. The drug of the month. Venlafaxine (Efexor)].
    Revue medicale de Liege, 1998, Volume: 53, Issue:2

    Topics: Antidepressive Agents, Second-Generation; Blood Pressure; Cyclohexanols; Depression; Drug Administration Schedule; Humans; Hypertension; Nausea; Selective Serotonin Reuptake Inhibitors; Therapeutic Equivalency; Venlafaxine Hydrochloride

1998
Venlafaxine withdrawal syndrome.
    Australian and New Zealand journal of medicine, 1998, Volume: 28, Issue:2

    Topics: Cyclohexanols; Depressive Disorder; Electroconvulsive Therapy; Humans; Male; Middle Aged; Nausea; Selective Serotonin Reuptake Inhibitors; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride

1998
Venlafaxine withdrawal reactions.
    The Medical journal of Australia, 1998, Jul-20, Volume: 169, Issue:2

    Topics: Adult; Antidepressive Agents, Second-Generation; Anxiety; Cyclohexanols; Depression; Depressive Disorder; Dizziness; Fatigue; Female; Hallucinations; Headache; Humans; Male; Middle Aged; Nausea; Sensation Disorders; Substance Withdrawal Syndrome; Tinnitus; Venlafaxine Hydrochloride

1998
Fluoxetine (Sarafem) for premenstrual dysphoric disorder.
    The Medical letter on drugs and therapeutics, 2001, Jan-22, Volume: 43, Issue:1096

    Topics: Adult; Clinical Trials as Topic; Cyclohexanols; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Female; Fluoxetine; Humans; Nausea; Premenstrual Syndrome; Selective Serotonin Reuptake Inhibitors; Sertraline; Venlafaxine Hydrochloride; Weight Gain

2001
Venlafaxine withdrawal syndrome not prevented by maprotiline, but resolved by sertraline.
    The international journal of neuropsychopharmacology, 2001, Volume: 4, Issue:1

    Topics: Aged; Antidepressive Agents, Second-Generation; Cyclohexanols; Female; Humans; Maprotiline; Nausea; Selective Serotonin Reuptake Inhibitors; Sertraline; Sleep Initiation and Maintenance Disorders; Substance Withdrawal Syndrome; Venlafaxine Hydrochloride

2001